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Abstract
T cells mediate the inflammatory responses observed in asthma among genetically susceptible individuals and have been
suspected to be prone to epigenetic regulation. However, these relationships are not well established from past clinical
studies that have had limited capacity to control for the effects of variable genetic predisposition and early environmental
exposures. Relying on a cohort of monozygotic twins discordant for asthma we sought to determine if epigenetic
modifications in T cells were associated with current asthma and explored whether such modifications were associated with
second hand smoke exposures. Our study was conducted in a monozygotic twin cohort of adult twin pairs (n = 21) all
discordant for asthma. Regulatory T cell (Treg) and effector T cell (Teff) subsets were assessed for levels of cellular function,
protein expression, gene expression and CpG methylation within Forkhead box P3 (FOXP3) and interferon gamma-c (IFNc)
loci. Comparisons by asthma and current report of exposure to second hand smoke were made. Treg from asthmatic
discordant twins demonstrated decreased FOXP3 protein expression and impaired Treg function that was associated with
increased levels of CpG methylation within the FOXP3 locus when compared to their non-asthmatic twin partner. In parallel,
Teff from discordant asthmatic twins demonstrated increased methylation of the IFNc locus, decreased IFNc expression and
reduced Teff function when compared to Teff from the non-asthmatic twin. Finally, report of current exposure to second
hand smoke was associated with modifications in both Treg and Teff at the transcriptional level among asthmatics. The
results of the current study provide evidence for differential function of T cell subsets in monozygotic twins discordant for
asthma that are regulated by changes in DNA methylation. Our preliminary data suggest exposure to second hand smoke
may augment the modified T cell responses associated with asthma.
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Introduction
Despite the rising rates of asthma prevalence and recent
advancements in the use of genome-wide association studies, the
mechanisms underlying the immunopathogenesis of asthma have
yet to be elucidated. Substantial evidence suggests that several
environmental exposures are important to the development of
asthma. Past cohort studies have been limited by the ability to
control for key confounders such as genetic predisposition and
early environmental exposures [1]. Hence, studies among twins,
monozygotic twins (MZT) in particular, have great potential to
provide critical information on the role of genetic predisposition
given the expected high concordance rate for asthma in twin pairs
[2]. In addition to their identical genetic background, MZTs have
similar childhood environmental exposures (i.e. diet, residential
environment, maternal smoking, sibling order). The heritability of
asthma has been reported to vary between 52–75% [3] leaving
room for environmental contributions. Previous studies have
identified childhood second hand smoke (SHS) as one of the
environmental triggers associated with asthma [4,5,6,7]. Although
there is a strong link between SHS and asthma in adults and
children [7,8,9,10], the mechanisms are not well established;
previous studies were not able to control for genetic makeup as we
were able to do in the MZT cohort used in the current study.
Among the molecular changes suspected to be important in the
development of asthma is altered regulation of CD4+CD25highC-
D127low/2 regulatory T cell (Treg) and CD4+CD25neg effector T-
cell (Teff) function, whereby the former contributes to airway
immune tolerance and the latter to airway inflammation [11]. Our
laboratory and others have reported that in asthmatic individuals
such cellular mechanisms appear dysfunctional in T cells from
bronchoalveolar lavage fluid (BAL) and peripheral blood (PB) [12–
13]. Treg development and function appear to be strongly
correlated with activation of the Forkhead box P3 (FOXP3)
transcription factor, as low FOXP3 transcription and expression is
consistently associated with reduced Treg function [14]. Control of
FOXP3 expression is, in part, mediated by epigenetic modifica-
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tions of the FOXP3 gene, including DNA methylation. For
example, increased levels of methylation of CpG sites within the
FOXP3 locus decreased expression of FOXP3 and subsequent
Treg function [15,16]. Recently, studies from our lab demonstrat-
ed a role for epigenetics in regulating asthma as increased CpG
methylation of FOXP3 reduced lung function and increased
asthma diagnosis [11]. Teff phenotype and function also appear to
be under regulation of epigenetic modifications as methylation of
key CpG sites within the IFNc locus leads to decreased IFNc
expression within Teff, and skews Teff towards a T helper (Th)
type 2 phenotype associated with asthma [12,17]. Thus, epigenetic
modifications of T cell subsets may influence the pathological
mechanisms of asthma.
We hypothesized that functional impairment of Treg and Teff
cells are due to epigenetic and molecular modifications in FOXP3
and IFNc that are mechanistically linked to outcomes of asthma.
To address this hypothesis, we conducted cellular and molecular
studies at the functional, protein, transcript and epigenetic level of
FOXP3 and IFNc in purified T cell subsets among MZT
discordant for asthma. We also explored whether report of
exposure to SHS was associated with altered DNA methylation.
Our investigation demonstrates that an increase in methylation of
CpG sites within FOXP3 and IFNc results in decreased protein
expression and is associated with impaired T cell function that
vary by SHS exposure and asthma diagnosis among MZT.
Furthermore, the current study reports on the use of the candidate
gene approach in epigenetic studies to trace the outcomes of a
molecular change in a specific cell subtype to a functional




The study was approved by the Stanford Institutional Review
Board. Written informed consent was obtained by all participants
or their parents (if ,18 years of age) before participating in the
study.
Human Subjects
Twenty one pairs of monozygotic twins (MZTs) ranging 9 to 76
years old (average age 33) were recruited from the Twin Research
Registry (TRR) at SRI International, Menlo Park, CA [18,19],
from Stanford University (Stanford, CA), and from Boston,
Massachusetts. Our cohort consisted of MZT pairs discordant
for asthma diagnosis (of which, six pairs were discordant for SHS
exposure). Subjects were interviewed to determine medical history,
disease onset and diagnosis, medication status, exposure to tobacco
smoke and resident zip codes in the last 20 years. Patient
demographics are summarized in Table 1. All subjects underwent
pulmonary function testing (Koko Legend Spirometer). Asthma
was defined by NHLBI criteria (EPR 2003). SHS exposure
definition was used as per U.S. Surgeon General’s report (2006,
2010) and response to SHS questionnaire [20]. Subjects were
excluded for any diagnosis of inflammatory condition (for
example, viral illness or asthma exacerbation), obesity, allergy
(for example, allergic rhinitis), autoimmune disease, cardiovascular
disease, cancer, COPD or diabetes. No subject with a history of
smoking, who currently smoked tobacco, or had in utero or
childhood exposure to SHS was enrolled. Current exposure to
SHS is defined as exposure in the last 5 years. No socioeconomic
data were collected. None of the subjects that were sampled were
on medications that were thought to be associated with
modulating DNA methylation and/or T cell function (i.e. oral
steroids or antiproliferatives).
Cell Isolation and Functional Assays
Treg and Teff were purified from up to 100 mL of peripheral
whole blood (PB) from all subjects. All cell numbers were
controlled for to decrease variability in comparison measurements
between subjects. In addition, bronchoalveolar lavage (BAL)
(n = 4 MZT pair) was collected from some subjects according to
published procedures [16,21]. CD4+ cells were isolated from each
sample (Stem Cell Technologies) followed by staining and isolation
of CD4+ CD25neg Teff and CD4+CD25hiCD127lo/2 Treg subset
populations to over 95% purity via FACS sorting (FACS Aria, BD
Biosciences).
T cell functional assays were performed in round-bottom 96-
well microtiter plates according to previously published methods
[16] and further detail on these methods can be found in Data S1.
Tetanus titers on subject plasma were determined using standard
assays in the Stanford Hospital Clinical Laboratories with subject
plasma and are expressed as units/mL.
Table 1. Subject demographics for twins discordant for asthma.
Variable Asthmatic N (%) Non-asthmatic N (%)
Age Mean (years) 33 33
Age Range (years) 9–76 9–76
Male 14 (33.3) 14 (33.3)







Recent second hand smoke exposure 6(14.2) 0 (0)
*Significant differences between asthmatic and non-asthmatic twins, P,0.05.
doi:10.1371/journal.pone.0048796.t001
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Flow Cytometry
Cells were fixed with Lyse/Fix PhosFlow buffer (BD Bioscienc-
es). For intracellular staining, fixed cells were permeabilized with
Perm Buffer III (BD Biosciences) at 4uC for 30 minutes, followed
by staining at 4u for 20 minutes. Flow cytometry was performed
with an LSRII flow cytometer (BD Biosciences). Viable cells were
identified with a live/dead probe (Invitrogen). Phenotypes of T
cells were detected with antibodies against surface CD3, CD4,
CD25, CD127 (BD Biosciences), and intracellular IFNc (BD
Biosciences) and FOXP3 (BioLegend) and stained per manufac-
turer’s recommended protocol.
Quantitative PCR and Methylation Analysis
Total RNA or genomic DNA was isolated from purified Treg or
Teff populations using the RNAeasy kit or the DNAeasy kit,
respectively, according to the manufacturer’s protocol (Qiagen).
For quantification of methylation within the FOXP3 and IFNc
loci, bisulfite modification of 1–2 mg of genomic DNA was
performed using CpGenome Fast DNA modification kit (Chemi-
con International). Identification of the FOXP3 CpG loci of
interest are based on our previous studies [21] and included a total
of 13 CpG sites within the promoter and intronic region of
FOXP3. For methylation analysis of IFNc, five amplicons were
amplified by using a HotStar Taq kit (Qiagen) and included a total
of six CpG sites within the proximal promoter region of IFNc. To
display methylation data, we first obtained pyrosequencing data as
to whether a particular CpG site was methylated (a threshold of
70% or higher methylation frequency was considered a methyl-
ated CpG site) in purified T cells that were controlled for cell
number. Then, to calculate a separate % of CpG sites for a given
locus, we divided the total number of methylated CpG sites
(numerator) for a specific genetic locus (for example, either
FOXP3 or IFNc) by the total CpG sites sequenced (denominator)
and used this % in our figures presented here. Further details on
quantification of gene transcripts and measures of DNA methyl-
ation can be found in Data S1.
Statistical Analysis
Laboratory data were assessed for normality and transformed if
needed, before being subjected to appropriate statistical tests.
Between-group means were compared with nonparametric
Kruskal-Wallis ANOVA and pairwise post-test comparisons via
the Dunn multiple comparison test (Graph Pad Prism Software
5.0; Prism Software). Sample size calculations based an increase in
% CpG methylation of the FOXP3 locus in purified Treg cells by
40% showed that the study achieved adequate power (93%) with a
95% confidence interval using n= 42 subjects (n = 21 pairs
discordant for asthma). Statistical differences in transcript, protein
and CpG methylation levels between asthmatic and non-asthmatic
twin pairs were assessed via the paired t-test. Linear regression was
applied for comparison between FOXP3 transcript level and
percentage of methylated CpG sites within FOXP3 and,
separately, IFNc. CpG sites with a methylation level that exceeded
70% was classified as methylated. For each sample, the percentage
of individual CpG sites exhibiting methylation was compared, and
fit without intercept using SAS v9.1 (SAS Institute, Cary, NC).
The threshold for all statistical significance was set at a p-value
,0.05. Geographic Information Systems were used analyzed by
Sonoma Technologies using California Air Resources Board and
EPA Air Pollution Monitoring Data (Dr. Fred Lurmann) to




Twenty-one pairs discordant for asthma were analyzed. None of
the non-asthmatic subjects had evidence of current smoking
exposure in their home. Interestingly, of the subjects who were
exposed to SHS, all had asthma as defined by NHLBI 2007
guidelines. As a group, asthmatic twins had increased total IgE as
compared to the non-asthmatic twins (Table 1).
Reduced T Cell Function in Asthmatic Twins
To address the hypothesis that functional impairment of Treg
and Teff cells are due to molecular modifications in FOXP3 and
IFNc that are linked mechanistically to outcomes of asthma, we
first determined the extent to which Treg and Teff cell function
was impaired in the MZT with asthma vs. the paired MZT
without asthma. Our laboratory has previously published on the
presence of dysfunctional Treg in the PB and bronchoalveolar
lavage fluid (BAL) of asthmatic subjects using standard prolifer-
ation assays [16]. We tested the suppressive activities of Treg
against autologous responder Teff and found that function of PB
Treg from asthmatic twins was significantly lower when compared
to non-asthmatic twins (Figure 1A, p,.05). Bronchoalveolar
lavage fluid (BAL) Treg function was not analyzed due to limited
number of Treg available for functional assays. In parallel,
function of Teff from twin pairs discordant for asthma was assessed
by proliferation assays to tetanus antigen. Teff from asthmatic
twins showed reduced proliferation to tetanus antigen compared to
non-asthmatics in our twin cohort (Figure 1B, p,.05). Tetanus Ig
titers were not significantly different between asthmatic and non-
asthmatic twins (Figure S1). These ex-vivo data suggest that Treg
and Teff immune function is reduced in asthmatics.
Lower Expression of FOXP3 and IFNc in Treg and Teff,
Respectively, in Asthmatics
Since we observed decreased Treg function in asthmatic twins
(Figure 1), we next assessed the relative levels of FOXP3 protein
and transcription in Treg from MZT discordant for asthma. We
found that the asthmatic twins had significantly lower expression
of FOXP3 as compared to Treg from their non-asthmatic twin
(Figure 2A, p,.001). Reduced transcript levels were associated
with reduced FOXP3 protein levels in Treg from asthmatic twins
as determined by intracellular flow cytometry (Figure 2B, p,.001).
IFNg is one of the key cytokines produced by Th1 CD4+ Teff
cells. As we also observed decreased Teff function from asthmatic
twins, we wanted to assess whether IFNc expression varied by
asthma. Therefore, we measured the protein levels and gene
transcripts for IFNc from peripheral blood Teff. Teff from
asthmatic twins had reduced transcript expression and significantly
decreased IFNc protein expression as compared to non-asthmatic
twins (Figure 2C and D, p,.001). These data indicate that
proteins and gene transcripts known to be important for Teff
(IFNc) and Treg (FOXP3) function are modified during asthma in
this MZT cohort.
Epigenetic Modification of T Cells during Asthma
Previous studies have demonstrated that epigenetic modifica-
tions in CpG-rich regions within the FOXP3 locus are associated
with stable FOXP3 expression [15,22,23]. Because we observed
differential levels of FOXP3 transcript between MZT pairs
discordant for asthma, we next determined whether changes in
FOXP3 expression were associated with altered DNA methyla-
tion. Using pyrosequencing technology, we assessed the methyl-
ation status of 13 CpG sites within FOXP3 and found that CpG
Epigenetic Modifications of T Cells during Asthma
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sites within FOXP3 from purified Treg were roughly six times as
methylated in the asthmatic MZT vs. the non-asthmatic MZT
(Figure 3A, p = .0003). Similar results were found in Treg purified
from bronchoalveolar lavage fluid (BAL) from a limited number of
twin pairs (Figure 3B). Linear regression and Spearman’s
correlation analysis between levels of FOXP3 protein and FOXP3
CpG methylation demonstrated an association between decreased
CpG methylation and higher FOXP3 expression in Treg
(Figure 3C, r = 0.81). Similar analysis of the levels of FOXP3
transcript and FOXP3 CpG methylation demonstrated an
association between decreased CpG methylation and higher
FOXP3 expression in Treg (Figure 3D, r = 0.88). These data
suggest that there is differential epigenetic regulation of FOXP3 in
MZT pairs discordant for asthma.
To determine if epigenetics were involved in the observed
differences in IFNc expression in Teff from the asthmatic twins,
we also assessed CpG methylation of six CpG sites in the IFNc
locus. Similar to our FOXP3 data, we observed an increase in the
percentage of CpG sites methylated within the IFNc locus in
asthmatic Teff as compared to Teff from their non-asthmatic twin
(Figure 3E, p = 0.016). Due to unavailability of IFNc methylation
primers at the time bronchoalveolar lavage fluid (BAL) cells were
collected, bronchoalveolar lavage fluid (BAL) Teff were not
assessed for methylation of CpG sites within the IFNc locus.
Collectively, the data in Figure 3 suggest that T cells are modified
at a DNA level during asthma.
Modifications of FOXP3 and IFNc are Associated with
Report of Current SHS among Asthmatics
Several of the asthmatic twins demonstrated very low levels of
FOXP3 and IFNc expression (Figure 2), and we were interested in
determining if environmental SHS affected T cell protein
expression and function in these asthmatic twins. Additionally,
epigenetic modifications of DNA are, in part, mediated by SHS
[24,25]. Thus, we further explored if known recent (in the last 5
years) SHS exposure was associated with the modified gene
expression and CpG methylation differences we observed between
the asthmatic vs. non-asthmatic MZT twin pairs. When FOXP3
expression was measured, we found that FOXP3 expression was
the lowest in Treg from the 6 asthmatic twins with current SHS
exposure as compared to asthmatics without SHS or non-
asthmatic twins (Figure 4A, p,.05). A parallel decrease in FOXP3
protein levels in Treg from asthmatic twins with current SHS
exposure was observed (Figure 4B, p,.05).
We also assessed Teff from the six MZT pairs discordant for
both asthma and SHS exposure for levels of IFNc. As shown in
Figure 4C and D, both IFNc transcript level and protein
expression is decreased further in asthmatic twins with current
SHS exposure as compared to their non-asthmatic twin or
asthmatic twins without current SHS exposure (Figure 4, p,.05).
In addition, we assessed the level of CpG methylation of FOXP3
and IFNc in Treg and Teff, respectively, from twins with recent
SHS exposure vs. those twins with no recent SHS exposure. Our
data demonstrate a significant increase in the level of methylation
of CpG sites within FOXP3 loci with recent SHS exposure as
compared to individuals with no recent SHS (Figure 5A, p,.05).
Linear regression and Spearman’s correlation analysis of FOXP3
transcript and CpG methylation within the FOXP3 locus of Treg
from asthmatic subjects either with or without SHS are presented
in Figure S2. In addition, we also examined two pairs of twins that
were concordant for SHS exposure but with no asthma (FigureS3).
In a small (n = 4) sample set, we found that these twins had some,
but not full, CpG methylation in the FOXP3 locus (mean 34%:
range 31–38%) vs. twins with no asthma and no SHS exposure
(mean 7%: range 3–12%).
The amount of methylation of the IFNc locus in Teff from
asthmatics with SHS tended to be higher than that in Teff from
asthmatics without SHS or non-asthmatics, but these data did
reach significant values (Figure 5B). These data indicate that
recent SHS exposure may modify T cells at the DNA level and
augment the reduced FOXP3 and IFNc expression occurring in T
cells during asthma.
Figure 1. Differential T cell function between asthmatic and non-asthmatic twins. Function of purified Treg (A) and purified Teff (B) from
non-asthmatic twins (n = 21, white bars) and their asthmatic (n = 21, black bars) twin partner was assessed via 3H-thiymidine incorporation. A)
Suppressive function of purified CD4+CD25+ Treg to CD4+ CD25neg Teff is presented as % function. B) Proliferation of purified CD4+ Teff to tetanus
antigen. Data are presented as mean 6 SD, * p,.05.
doi:10.1371/journal.pone.0048796.g001
Epigenetic Modifications of T Cells during Asthma
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Impairment of Teff Function and Ig Production in
Asthmatics with Recent SHS
The impaired IFNc production observed in asthmatic patients
with recent SHS led us to test whether Teff function in subjects
with SHS in our MZT cohort was further impaired. Proliferation
of Teff to tetanus antigen was reduced in asthmatic twins with
SHS as compared to their non-asthmatic twin (Figure 6A, p,.05).
Ig production can be indicative of both T and B cell function. We
additionally assessed tetanus-specific Ig in asthmatics with SHS
and found that tetanus Ig titers were significantly reduced in the
asthmatic twins with SHS as compared to their non-asthmatic
twin partners (Figure 6B, p,.05). These data suggest that Teff and
B cell function likely are affected by environmental SHS.
Treg exert a direct effect on B cells, suppressing the production
of allergen-specific IgE and inducing IgG4 [26]; reduced FOXP3
expression, and subsequent reduction in Treg function, has been
implicated with elevated IgE levels in both human and mouse
studies [22,27,28,29]. To determine if there was an association
between Treg function and IgE, we quantified total serum IgE
levels in our MZT cohort. Figure 6C shows that asthmatics with
SHS had increased total IgE as compared to asthmatics with no
SHS (p,.05). Collectively, the ex-vivo functional data presented in
Figure 2. Reduced expression of proteins involved in Teff and Treg function during asthma. A) FOXP3 gene expression and B) FOXP3
protein was assessed from purified Treg from asthmatic and non-asthmatic twin pairs. In C) IFNc gene expression and D) IFNc protein levels were
assessed from purified Teff cells from asthmatic and non-asthmatic twin pairs. Gene expression was determined by QT-PCR and is shown as relative
fold expression of candidate genes to expression of the housekeeping gene b-glucuronidase. Protein levels were determined by intracellular flow
cytometry and shown as mean fluorescence intensity (MFI). Data points represent individuals and twin pairs are connected via lines, * p,.001.
doi:10.1371/journal.pone.0048796.g002
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Figure 6 suggest that SHS impairs T cell, and possibly B cell,
function in asthmatics and further suggest that these impairments
are due to environmental and not genetic influences.
Discussion
Data presented in this study demonstrated an association
between increased CpG methylation and decreased FOXP3 and
IFNc expression in Treg and Teff that was linked to cellular
dysfunction. This is the first study to our knowledge that provides
data from MZT to trace plausible mechanistic pathways from
molecular events (i.e. DNA methylation of CpG sites) in specific
genes (i.e. FOXP3 and IFNc) to transcript, to protein, to cellular
changes and then to clinical outcomes and immune function
(specifically, total IgE levels and tetanus response). Moreover, T
cell modifications of FOXP3 and IFNc were amplified in the
MZT with recent SHS vs. the paired MZT without recent SHS.
As shown in previous studies, CpG methylation can be induced
through epigenetic mechanisms and triggered via environmental
exposures [16,30,31]. A recent study demonstrated that buccal
mucosa cells from children exposed to maternal smoking in utero
had differences in global and gene-specific DNA methylation, and
that the long-term effects of in utero tobacco smoke exposure may
be mediated through DNA methylation [24,25]. We were
interested in the effects of recent SHS exposure (in the last 5
years) and did not include subjects with a history of smoking or a
history of childhood/in utero exposure or who currently smoked.
Epigenetic changes have been shown to affect FOXP3 and IFNc
expression and mutations and/or deficiencies in FOXP3 or IFNc
can result in development in autoimmune disease, infections or
asthma [30,32]. The methylation data in our study were not
Figure 3. Epigenetic modification of FOXP3 and IFNc during asthma. Treg were purified from the PB (A, n = 21) or bronchoalveolar lavage
(BAL) (B, n = 4) of MZT pairs discordant for asthma and methylation of 13 CpG sites within the FOXP3 locus was quantified. A CpG site was considered
methylated after exhibiting methylation at that CpG site in $70% of the pyrosequencing reactions. Linear regression and Spearman’s correlation
analysis of C) FOXP3 protein and % of methylated CpG sites within FOXP3(% calculated as number of methylated CpG sites divided by total number
of CpG sites in the FOXP3 locus) or D) FOXP3 transcript (fold expression) and % of methylated CpG sites within FOXP3. E) Teff were purified from
asthmatic and non-asthmatic MZT pairs (n = 21) and methylation of 6 CpG sites within the IFNc locus was quantified. Data points represent
individuals and twin pairs are connected via lines, r = correlation coefficient.
doi:10.1371/journal.pone.0048796.g003
Figure 4. Reduction of FOXP3 and IFNc is augmented with recent SHS exposure. Peripheral blood Treg or Teff (CD4+CD25neg) were
purified from twin pairs discordant for asthma and concordant for no SHS exposure (n = 15) and discordant for both asthma and SHS exposure (n = 6).
In A and B, Treg were assessed for FOXP3 transcript (A) and FOXP3 protein (B). In C and D, Teff were assessed for IFNc transcript (C) and protein (D).
Gene expression was determined by QT-PCR and is shown as relative fold expression of candidate genes to expression of the housekeeping gene b-
glucuronidase. Protein levels were determined by intracellular flow cytometry and shown as mean fluorescence intensity (MFI). Data points (circles)
represent individuals and individual twin pairs are connected via a line, p,.05 for non-asthmatic vs. asthmatic or asthmatic + SHS for all groups.
doi:10.1371/journal.pone.0048796.g004
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unique to one tissue region but were found to be different in some
discordant pairs in both the PB and BAL, suggesting similar
immunological mediator function at different tissue sites. Howev-
er, increased numbers of subjects in studies focused on CpG
methylation in specific cells and tissues are necessary to be able to
further determine mechanistic pathways that link a molecular
Figure 5. Increased epigenetic modification of T cells with current SHS exposure during asthma. Peripheral blood CD4+CD25+ Treg or
CD4+CD25neg Teff were purified from twin pairs discordant for asthma and concordant for no SHS exposure (n = 15) and discordant for both asthma
and SHS exposure (n = 6). Genomic DNA was sequenced for methylation of CpG sites within A) FOXP3 or B) IFNc. *p,.05, n.s.: not significant.
doi:10.1371/journal.pone.0048796.g005
Figure 6. Decreased immune function in asthmatics with SHS. Immune parameters from MZT pairs discordant for asthma (n = 15 non-
asthmatic (Twin A) and asthmatic (Twin B)) or MZT pairs discordant for both asthma and SHS (n = 6 non-asthmatic (Twin A) and asthmatic + SHS (Twin
B) were assessed. A) Teff proliferation to tetanus antigen. B) Tetanus Ig titers. C) Total serum IgE titers. Data are presented as mean 6 SD, *p,.05.
doi:10.1371/journal.pone.0048796.g006
Epigenetic Modifications of T Cells during Asthma
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event to disease outcome. Even though we observed decreased
IFNc gene and protein expression in asthmatic twins with SHS,
there was not a significant increase in methylation of the six CpG
sites we analyzed. Additional studies will include the assessment of
all CpG methylation sites within the IFNc locus. Finally, further
detailed mechanistic studies on the correlation between DNA
methylation of FOXP3 and IFNc in Treg and Teff, respectively,
and disease state are warranted.
As DNA methylation has been associated with age, a potential
confounder in our study is age of each twin pair. Previous studies
have elegantly demonstrated that certain genes are either hyper-
or hypo-methylated with age in MZTs however, these studies did
not identify DNA modification of FOXP3 or IFNc with respect to
age in different T cell subsets [33,34,35]. When we assessed age
and CpG methylation of either FOXP3 or IFNc in purified T cell
subsets in our twin cohorts to date we did not find an association;
however, further studies with twin subjects at different age ranges
would be needed to optimally determine associations between age
(neonatal to geriatric) and CpG methylation of FOXP3 or IFNc.
So far to date, our analysis shows that, even within the same twin
pair (i.e. naturally controlled for age) there are statistically
significant differences in methylation events.
The effects of SHS on the immune response are an important,
but understudied, area of focus. To fully test the interaction of
environmental exposures between genetic predisposition and
disease outcomes of asthma, broader studies including concordant
and discordant twins for SHS with and without asthma are
needed. However, our preliminary data suggest that recent SHS
induces epigenetic modifications in IFNc and FOXP3 in Teff and
Treg populations, respectively, and results in impaired cellular
function.
In choosing an approach that included MZT, we were able to
eliminate confounding factors such as genetic background, in utero
exposure, major childhood exposures, age, and sex. There is
evidence emphasizing the genetic heritability of asthma [13];
however, environmental factors play an important role in
mediating epigenetic events that are also associated with disease
outcome. In this study, we began to investigate potential effects of
the environmental factors outside of SHS, for example, air
pollution, on Teff and Treg function. Although a geographical
information system (GIS) analysis of our cohort thus far has
yielded no significant differences in PM2.5 and PM10, these data
analyses were limited to n= 10 pair of discordant asthma twins;
therefore, we will continue to examine correlations between GIS
and DNA methylation in the MZT.
We recognize that more twins with SHS exposure and no
asthma are needed. Moreover, studying twin pairs longitudinally
will enable a better understanding of the possible molecular
linkage between lung disease and methylation of CpG sites in
FOXP3 and IFNc in Treg and Teff, respectively.
Our data demonstrated an association between Treg impair-
ment and total IgE (Figure 6C). In both mice and human,
impaired Treg function is associated with increased IgE and atopic
conditions. Scurfy mice, which present a deletion in Foxp3, have
impaired capacity to generate natural Treg, or mice depleted of
Foxp3+ Treg have elevated IgE levels [28,36]. In humans, single
nucleotide polymorphisms of FOXP3 are associated with atopic
pathologies in childhood, including increased IgE levels [27].
Additionally, the rare disorder of the immune system, immune
dysregulation, polyendocrinopathy, enteropathy X-linked (IPEX)
syndrome, is caused by mutations in the FOXP3 gene that result
in defective development of CD4+ CD25+ Treg; children with
IPEX syndrome demonstrate high levels of serum IgE (reviewed in
[37]).
As Treg are major components in both the induction and the
maintenance of tolerance, interfering with Treg function (at the
DNA level as observed in our study) could affect responses
downstream of any Treg function (i.e. production of TGFb or
IL10, inhibition of Th2 cells and dampening of inflammatory
responses). The data on T cell modifications induced by SHS we
present in this study may influence multiple arms of the immune
system including B cells, T cells, mast cells and NK cells.
In conclusion, our study demonstrated a reduction in FOXP3
and IFNc expression and Treg and Teff function in asthmatic
MZT associated with epigenetic changes in the FOXP3 and IFNc
genetic loci. In addition, our data suggest that recent SHS may
have a significant effect on methylation levels in these genes and
subsequent impairment of cellular function of T cells. Through
data presented in the current study, we begin to address the
epigenetic consequences of exposure to SHS, and how these in
turn are associated with asthma. The two key unique elements to
this study that enabled us to begin to fill this gap include 1)
enrollment of MZTs, including those discordant for exposure to
SHS and discordant for asthma, to eliminate genetic predisposi-
tion and differing in utero and early environmental exposures as
confounders, and 2) focus on molecular events that likely vary by
T cell type. Our data so far suggest that epigenetic modifications
may be cell specific. This unique approach and these two key
elements have begun to overcome limitations from past studies.
Our study represents an important approach in epigenetic studies
since we use hypothesis-driven, candidate genes to link outcomes
of a molecular change in a specific cell subtype to a functional
consequence that could lead to a clinically significant health effect
in humans.
Supporting Information
Figure S1 Tetanus Ig titers in MZT pairs discordant for asthma.
Non-asthmatic twins (white bar) vs. asthmatic twins (black bar).
(TIF)
Figure S2 Linear regression analysis of FOXP3 expression and
CpG methylation within the FOXP3 locus of asthmatics. A)
Asthmatic MZT subjects with no SHS (n= 15) and B) All
asthmatic MZT subjects with SHS exposure (n = 6).
(TIF)
Figure S3 FOXP3 CpG methylation analysis in non-asthmatic
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